by ODWAdmin | Sep 22, 2025
Comprehensive Biological Profiling in Cancer via Multi-Omics Integration Colorectal cancer is on the rise and remains difficult to detect and treat. Panome Bio’s multi-omics platform combines metabolomics and proteomics to reveal how molecules interact across...
by ODWAdmin | Sep 18, 2025
Revolutionize Your Microbiome Research with Panome Bio’s Advanced Functional Analysis The gut microbiome, a community of microorganism, influences host digestion, immunity, neural signaling and metabolism. Discover how Next-Generation Metabolomics reveals...
by ODWAdmin | Sep 8, 2025
Combining Metabolomics, Proteomics and Transcriptomics to Reveal Key Pathways and Biomarkers Explore how reduced KRAS activity reshapes gene expression and pathway activity in HCT-116 cells. In this application note, Panome Bio combines next-generation metabolomics,...
by ODWAdmin | Sep 6, 2025
TissueBridge™ Metabolomics | A Validated Workflow for FFPE Tissue Panome Bio is excited to announce a new, fully validated service that brings comprehensive, untargeted metabolomics to formalin-fixed paraffin-embedded (FFPE) samples, TissueBridge Metabolomics....
by ODWAdmin | Sep 2, 2025
Next-Generation® Metabolomics for Mechanism of Action Analysis Next-Generation Metabolomics can provide robust, biologically meaningful data for drug combination analysis. Learn more about treatment-induced metabolic reprogramming and targeted combination therapies in...
